vision loss tirzepatide reduces food intake and appetite, and affects brain functioning, more than placebo and liraglutide Vision loss: GLP-1 drugs like

Dizziness associated with Mounjaro may be attributed to secondary effects such as dehydration, reduced caloric intake, rapid weight loss, or changes in blood pressure

K-Dense Web generated a complete competitive intelligence package for CT-388, covering pipeline mapping, receptor pharmacology, clinical efficacy, FAERS safety analysis, SWOT synthesis, and Phase III trial design recommendations

In all KO genotypes, cFos induction in the AP and NTS was markedly blunted compared to WT mice, establishing that both AMY1R and AMY3R are necessary for transmitting cagrilintides central effects

Tirzepatide adds GIPR receptor activation, which enhances insulin secretion further and may amplify appetite suppression through additional neural pathways